Skip to main content Accessibility help
  • Print publication year: 2019
  • Online publication date: June 2019

121 - Endocrine Disorders

from Section 2 - Medical Conditions and Symptoms
Alp, R., Saygin, M., Ucisik, M., et al. (2004). Initial presentation of Hashimoto’s thyroiditis with psychotic symptoms: a case report. Bulletin of Clinical Psychopharmacology, 14, 8387.
Arnaldi, G., Angeli, A., Atkinson, A. B., et al. (2003). Diagnosis and complications of Cushing’s syndrome: a consensus statement. The Journal of Clinical Endocrinology and Metabolism, 88, 55935602.
Auer, R. N. (2004). Hypoglycemic brain damage. Forensic Science International, 146, 105110.
Bahn, R. S., Burch, H. B., Cooper, D. S., et al. (2011). Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid, 21, 593646.
Bilezikian, J. P. & Silverberg, S. J. (2004). Asymptomatic primary hyperparathyroidism. New England Journal of Medicine, 350, 17461751.
Boscaro, M., Barzon, L., Fallo, F., et al. (2001). Cushing’s syndrome. Lancet, 357, 783791.
Cederlöf, M., Gotby, A. O., Larsson, H., et al. (2014). Klinefelter syndrome and risk of psychosis, autism and ADHD. Journal of Psychiatric Research, 48, 128130.
Chaplin, J. E., Kriström, B., Jonsson, B., et al. (2011). Improvements in behaviour and self-esteem following growth hormone treatment in short prepubertal children. Hormone Research in Paediatrics, 75, 291303.
Charan, A., Shewade, D. G., Rajkumar, R. P., et al. (2016). Relation between serum prolactin levels and antipsychotic response to risperidone in patients with schizophrenia. Psychiatry Research, 240, 209213.
Collins, M. M., Corcoran, P. & Perry, I. J. (2008). Anxiety and depression symptoms in patients with diabetes. Diabetic Medicine, 26, 153161.
Dayan, R. S. & Panicker, V. (2013). Hypothyroidism and depression. European Thyroid Journal, 2, 168179.
Downey, J., Ehrhardt, A. A., Gruen, R., Bell, J. J. & Morishima, A. (1989). Psychopathology and social functioning in women with Turner syndrome. Journal of Nervous and Mental Disorders, 177(4), 191201.
Flicker, L. & Ames, D. (2005). Metabolic and endocrinological causes of dementia. International Psychogeriatrics, 17, S79S92.
Forget, H., Lacroix, A., Somma, M., et al. (2000). Cognitive decline in patients with Cushing’s syndrome. Journal of the International Neuropsychological Society, 6, 2029.
Fries, E., Hesse, J., Hellhammer, J., et al. (2005). A new view on hypocortisolism. Psychoneuroendocrinology, 30, 10101016.
Geffken, G. R., Ward, H. E., Staab, J. P., et al. (1998). Psychiatric morbidity in endocrine disorders. The Psychiatric Clinics of North America, 21, 473489.
Hellhammer, J., Schlotz, W., Stone, A. A., et al. (2004). Allostatic load, perceived stress, and health: a prospective study in two age groups. Annals of the New York Academy of Sciences, 1032, 813.
Holt, R. I. G., de Groot, M. & Golden, S. H. (2014). Diabetes and depression. Current Diabetes Reports, 14 (6), 491.
Hong, D. S. & Reiss, A. L. (2012). Cognition and behavior in Turner syndrome: a brief review. Pediatric Endocrinology Reviews, 9(2), 710712.
Hwang, J. W. & Seo, J. Y. (2015). Parents’ perception about child’s height and psychopathology in community children with relatively short stature. Annals of Pediatric Endocrinology & Metabolism, 20, 7985.
Ladenson, P. W., Braverman, L. E., Mazzaferri, E. L., et al. (1997). Comparison of recombinant human thyrotropin administration to thyroid hormone withdrawal for radioactive iodine scanning in patients with thyroid carcinoma. New England Journal of Medicine, 337, 888896.
Michaud, K., Foget, H. & Cohen, H. (2009). Chronic glucocorticoid hypersecretion in Cushing’s syndrome exacerbates cognitive aging. Brain and Cognition, 71, 18.
Oelkers, W. (2000). Clinical diagnosis of hyper- and hypoconrtisolism. Noise & Health, 2, 3948.
Papa, A., Bononi, F., Sciubba, S., et al. (2003). Primary hyperparathyroidism: acute paranoid psychosis. American Journal of Emergency Medicine, 21, 250251.
Petty, R. G. (1999). Prolactin and antipsychotic medications: mechanism of action. Schizophrenia Research, 35, S67S73.
Radanovic-Grguric, L., Filakovic, P., Jelena, B., et al. (2003). Depression in patients with thyroid dysfunction. European Journal of Psychiatry, 17, 133144.
Sait Gonen, M., Kisakol, G., Savas Cilli, A., et al. (2004). Assessment of anxiety in subclinical thyroid disorders. Endocrinology Journal, 51, 311315.
Sharpe, L. & Curran, L. (2006). Understanding the process of adjustment to illness. Social Science & Medicine, 62, 11531166.
Sheehan, D. V. & Sheehan, K. H. (1982). The classification of anxiety and hysterical states: towards a more heuristic classification. Journal of Clinical Psychopharmacology, 2, 386393.
Shoback, D. M., Bilezikian, J. P., Costa, A. G., et al. (2016). Presentation of hypoparathyroidism: etiologies and clinical features. Journal of Clinical Endocrinology & Metabolism, 101, 23002312.
Silverberg, S. J., Walker, M. D. & Bilezikian, J. P. (2013). Asymptomatic primary hyperparathyroidism. Journal of Clinical Densitometry, 16, 1421.
Sonino, N. & Fava, G. A. (2001). Psychiatric disorders associated with Cushing’s syndrome: epidemiology, pathophysiology, and treatment. CNS Drugs, 15, 361373.
Storch, E. A., Lewin, A., Silverstein, J. H., et al. (2005). Psychological adjustment of children with short stature: a comparison of children with short stature and type one diabetes. Journal of Pediatric Endocrinology and Metabolism, 18, 395401.
Ulph, F., Betts, P., Mulligan, J. & Stratford, R. J. (2004). Personality functioning: the influence of stature. Archives of Disease in Childhood, 89, 1721.
Wild, S., Sicref, R., Rogilc, G., et al. (2004). Global prevalence of diabetes. Diabetes Care, 27, 10471053.